Karen V Kibler (Karen Kibler)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Multiple Myeloma

Monoclonal Antibody

Top Venues

EMBO molecular medicine

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Adrian Esqueda, Haiyan Sun, James Bonner, Huafang Lai, Collin Jugler, Karen V Kibler, Herta Steinkellner, Qiang Chen
A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus. Vaccines 11 (7) (2023)
Liqiang Zhang, Yize Henry Li, Karen V Kibler, Simona Kraberger, Arvind Varsani, Julie Turk, Nora Elmadbouly, Emily Aliskevich, Laurel Spaccarelli, Bereket Estifanos, Junior Enow, Isabela Rivabem Zanetti, Nicholas Saldevar, Efrem Lim, Jessika Schlievert, Kyle Browder, Anjali Wilson, Fernando Arcos Juan, Aubrey Pinteric, Aman Garg, Henna Monder, Rohan Saju, Savanah Gisriel, Bertram Jacobs, Timothy L Karr, Esther Borges Florsheim, Vivek Kumar, John Wallen, Masmudur M Rahman, Grant McFadden, Brenda G Hogue, Alexandra R Lucas
Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection. EMBO molecular medicine (2023)
Masmudur M Rahman, Bereket Estifanos, Honor L Glenn, Karen V Kibler, Yize Li, Bertram Jacobs, Grant McFadden, Brenda G Hogue
Nuclear export inhibitor Selinexor targeting XPO1 enhances coronavirus replication. bioRxiv : the preprint server for biology (2023)
Karen V Kibler, Mateusz Szczerba, Douglas Lake, Alexa J Roeder, Masmudur M Rahman, Brenda G Hogue, Lok-Yin Roy Wong, Stanley Perlman, Yize Li, Bertram L Jacobs
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y MA30 Strain of SARS-CoV-2. Vaccines 10 (8) (2022)